Search results (71)
« Back to NewsOxford gets £122m funding for healthcare research
19 October 2022
Awards & Appointments Research
Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.
Study raises hope of pre-school type 1 diabetes screening programme
6 September 2022
Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.
Angelman syndrome: first patient to receive potential therapy in Oxford
3 December 2021
Neuromuscular Diseases Research
Things that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.
New model for infant leukaemia announced
25 November 2021
Haematology Publication Research
The breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.
Why it's so hard to treat pain in infants
12 November 2021
Children's Health Neuroimaging Research
For decades physicians believed that premature babies didn’t experience pain. Here’s what doctors know now – and the innovative solutions being embraced by today's caregivers.
Oxford to work with Brazil to establish clinical research hub
8 November 2021
The University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.
New atlas revealed of bone marrow haematopoiesis during development
5 October 2021
Children's Health Haematology Immunology Research
A new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
Promising discovery for treatment of neuromuscular diseases
23 August 2021
Neuromuscular Diseases Publication Research
Research led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy, and shows potential for other diseases.
University of Oxford researchers among recipients of Ireland and UK joint research awards for digital humanities in €6.5m boost for interdisciplinary research partnerships
9 August 2021
Awards & Appointments Research
Dr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project ‘Typhoid, Cockles, and Terrorism’ about the history of typhoid in Dublin successfully funded.
Increasing vaccine uptake among ethnic minorities
6 May 2021
COVID-19 Public Engagement Research Vaccinology
Dr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.
Innovation award for Paediatrics researcher to develop new treatments for childhood cancer
18 March 2021
Awards & Appointments Haematology Research
Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.
Celebrating Early Careers Researchers on International Women's Day
8 March 2021
In these short interviews, Anna Kordala and Jane Millar talk about the research they do at the Department of Paediatrics.
Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests
24 February 2021
The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.
Oxford vaccine effective against major B.1.1.7 ‘Kent’ coronavirus strain circulating in the UK
5 February 2021
A preprint of ongoing work to assess effectiveness of Oxford’s ChAdOx1 coronavirus vaccine shows that the existing vaccine has similar efficacy against the B.1.1.7 ‘Kent’ coronavirus strain currently circulating in the UK to previously circulating variants.
Children’s pain ‘swept under the carpet for too long’ – Lancet Commission
22 October 2020
Neuroimaging Publication Research
The launch of Lancet Child and Adolescent Health Commission - the first ever to address paediatric pain - aims to raise the profile of children’s pain from early years to early adulthood.
Oxford COVID-19 vaccine begins human trial stage
24 April 2020
COVID-19 Recruitment Research Vaccinology
University of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine.
Funding for new COVID-19 studies awarded to OVG's project on infectious disease immunity in children
17 April 2020
Awards & Appointments COVID-19 Research Vaccinology
Five projects from across Oxford University's Medical Sciences Division, including a project led by Professor Matthew Snape from the Oxford Vaccine Group, are among twenty-one new studies into the novel coronavirus which have been funded by the UK government.
Visualising COVID-19 outbreak
2 April 2020
COVID-19 Neuroimaging Research Research Methods
Paediatric Neuroimaging researcher provides real-time case information on epidemiological data from the COVID-19 outbreak.
Oxford COVID-19 vaccine programme opens for clinical trial recruitment
27 March 2020
University of Oxford researchers working in an unprecedented vaccine development effort to prevent COVID-19 have started screening healthy volunteers (aged 18-55) today for their upcoming ChAdOx1 nCoV-19 vaccine trial in the Thames Valley Region. The vaccine based on an adenovirus vaccine vector and the SARS-CoV-2 spike protein is already in production but won’t be ready for some weeks still.
COVID-19 vaccine development
18 March 2020
A vaccine candidate for COVID-19 has been identified by researchers from the Oxford Vaccine Group and Oxford's Jenner Institute.